Merck 2017 forecast reassuring; full-speed ahead with Keytruda
Go back to Merck 2017 forecast reassuring; full-speed ahead with Keytruda| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 62.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.09 | 52 Week High | $77.12 | |||
| Open | $62.09 | 52 Week Low | $49.03 | |||
| Day High | $62.09 | P/E | 40.32 | |||
| Day Low | $62.09 | EPS | $1.54 | |||
| Volume | 1,523 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 131.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.07 | 52 Week High | $65.46 | |||
| Open | $131.07 | 52 Week Low | $47.97 | |||
| Day High | $131.07 | P/E | 89.16 | |||
| Day Low | $131.07 | EPS | $1.47 | |||
| Volume | 1,034 | |||||
